Dietary Oxysterols and β-Cell Function Among African Americans

Contact Information

Department Information

Community Health & Preventive Medicine

Principal Investigator

Jennifer Rooke, MD, MPh, FACOEM, FACPM

.

Coordinator

Clinicaltrials.gov Details

Identifier: NCT05073587

First Received Date: 10/11/2021

View on Clinicaltrials.gov

Purpose

To determine the effect of reducing exposure to dietary oxysterols on pancreatic β-cell function and glycemic control among AAs with prediabetes and early diabetes (HbA1c 5.7% - 7.0%). 7-KC will be used as a biomarker of serum oxysterols in this study.

Start Date : 5/17/2021

End Date: 12/31/22

Investigator(s)

Jennifer Rooke, MD, MPh, FACOEM, FACPM

Interventions:

Group A: Standard American Diabetes Association Diet

Group B: Plant-based American Diabetes Association Diet with no oxysterols

Eligibility

  • Ages Eligible for Study: Adults over 18 years old

    Sexes Eligible for Study: Both sexes – women and men

    Participants must
  • Have prediabetes or early diabetes - HbA1c: 5.7% - 7.0%
  • Not be taking on statin medications to lower cholesterol
  • Be able to commit to 12 weeks of participation in the study
  • Be non-smokers
  • Not be taking medications for diabetes
  • Be African American
  • Be able to store a week’s supply of prepared meals
  • Not be on dialysis
  • Have no food allergies or food restrictions
Top